Showing results (341-350 of 387) with videos related to

Sort By:
Pageof 39
Disease Models & Mechanisms|April 24, 2026
Evaluating skeletal muscle dysfunction and recovery in a zymosan model of critical illness in miceAmy J Bongetti, Annabel Chee, John H V Nguyen, et al.
Molecular & Cellular Oncology|September 26, 2018
CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges aheadEldad Zacksenhaus, Jeff C Liu, Letizia Granieri, et al.
Biochemical Pharmacology|May 5, 2022
A racemosin B derivative, C25, suppresses breast cancer growth via lysosomal membrane permeabilization and inhibition of autophagic fluxXiao Xiao, Philip E D Chung, Mei Xu, et al.
Experimental Cell Research|August 30, 2001
Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytesM Ranginwale, S Smith, J Flom, et al.
Acta Neuropathologica|October 30, 2007
Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamineWilliam J Burke, Vijaya B Kumar, Neeraj Pandey, et al.
Physical Review Letters|April 12, 2003
Spontaneous N incorporation onto a Si(100) surfaceJ W Kim, H W Yeom, K J Kong, et al.
European Journal of Human Genetics : EJHG|March 17, 2011
Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG)C M Laine, B D Chung, M Susic, et al.
Alcoholism, Clinical and Experimental Research|February 21, 2022
Gag-like proteins: Novel mediators of prenatal alcohol exposure in neural developmentMarisa R Pinson, Dae D Chung, Amanda H Mahnke, et al.
Ma Zui Xue Za Zhi = Anaesthesiologica Sinica|June 1, 1990
Suppression of hemodynamic change before extubation--lidocaine through modified endotracheal tubeT J Wu, K C Luu, S Y Lin, et al.
Neurotoxicology|December 31, 2003
Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseasesWilliam J Burke, Shu Wen Li, Hyung D Chung, et al.
Pageof 39